The purpose of this study is to determine whether restoring blood flow to all blocked or narrowed arteries via percutaneous coronary intervention (PCI) using coronary stents is better than treating the coronary artery disease (CAD) with medications in patients with CAD who had successful transcatheter aortic value replacement (TAVR) with a balloon expandable heart valve. The study will also compare measurements of hemodynamics (blood flow and blood pressure) that are taken during on-table procedures (TAVR and PCI) with those taken by echocardiography (heart ultrasound).
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
scri@sparrow.org
Principal investigator
Dr. Mohammed Qintar, MD
Trial Category
Heart & Vascular
Trial SubCategory
Cardiovascular Disease
Webform